Controlling Pharmaceutical Risks
-10%
portes grátis
Controlling Pharmaceutical Risks
Science, Cancer, and the Geneticization of Drug Testing
Ballinger, Rachel; Abraham, John
Taylor & Francis Ltd
06/2025
224
Dura
Inglês
9780415622479
Pré-lançamento - envio 15 a 20 dias após a sua edição
Descrição não disponível.
1. The Brave New World of Carcinogenic Risk Assessment 2. The Archaeology of Toxicology as Regulatory Science 3. The Internationalisation of Reduction in Drug Toxicology 4. Mechanising Cancer 5. Industrial Unrest, Scientific Uncertainty and the Political Economy of Sensitivity 6. Taking Risks - the Diffusion of Alternative Carcinogenicity Testing 7. Conclusion: Progress, Innovation and Regulatory Science
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
John Abraham;Controlling Pharmaceutical Risks;Science, Cancer, and the Geneticization of Drug Testing;Genetics and Society;drug testing;1990s;geneticization;carcinogenic risk assessment;regulation;pharmaceuticals;bio-science;medical treatment;patient health;techno-science;science and society;political economy;risk;activism;FDA;National Cancer Institute;International Life Sciences Institute;NCI;ILSI;National Institute of Environmental Health Sciences;NIEHS;Food and Drug Administration;science and technology studies;science policy
1. The Brave New World of Carcinogenic Risk Assessment 2. The Archaeology of Toxicology as Regulatory Science 3. The Internationalisation of Reduction in Drug Toxicology 4. Mechanising Cancer 5. Industrial Unrest, Scientific Uncertainty and the Political Economy of Sensitivity 6. Taking Risks - the Diffusion of Alternative Carcinogenicity Testing 7. Conclusion: Progress, Innovation and Regulatory Science
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
John Abraham;Controlling Pharmaceutical Risks;Science, Cancer, and the Geneticization of Drug Testing;Genetics and Society;drug testing;1990s;geneticization;carcinogenic risk assessment;regulation;pharmaceuticals;bio-science;medical treatment;patient health;techno-science;science and society;political economy;risk;activism;FDA;National Cancer Institute;International Life Sciences Institute;NCI;ILSI;National Institute of Environmental Health Sciences;NIEHS;Food and Drug Administration;science and technology studies;science policy
